Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders at four companies have recently made notable purchases of their own stock, indicating potential confidence in their companies' prospects. Tharimmune CEO Randy Milby bought 29,000 shares at $0.50 each. Perspective Therapeutics Director Lori A Woods acquired 185,200 shares at $0.27 each. SHF Holdings CEO Sundie Seefried and a Director purchased a total of 39,700 shares at around $0.96 each. Dalrada Financial CEO Brian Bonar bought 9,000 shares at $0.29 each. These transactions can be a factor for investors considering penny stocks.
December 19, 2023 | 1:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Perspective Therapeutics Director Lori A Woods acquired 185,200 shares, possibly indicating confidence after the company's decision to divest its brachytherapy business.
The director's substantial purchase could reflect a positive outlook on the company's future after divesting its brachytherapy business, which may streamline operations and focus on core areas.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 80
POSITIVE IMPACT
Dalrada Financial CEO Brian Bonar's purchase of 9,000 shares aligns with the stock's 26% rise over six months, potentially signaling sustained positive momentum.
The CEO's investment coincides with a recent uptrend in the stock price, which might suggest that the CEO expects the positive trend to continue or believes the stock is still undervalued.
CONFIDENCE 60
IMPORTANCE 55
RELEVANCE 70
POSITIVE IMPACT
SHF Holdings CEO Sundie Seefried and a Director bought shares despite a recent Q3 loss, which could suggest insider belief in the company's recovery or growth potential.
Insider purchases after a reported loss could indicate that the insiders believe the stock is undervalued or that they have confidence in the company's long-term prospects despite short-term setbacks.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 75
POSITIVE IMPACT
Tharimmune CEO Randy Milby purchased 29,000 shares, signaling potential insider confidence following the announcement of topline data for TH104.
The CEO's purchase is a strong vote of confidence, especially following recent topline data announcements which could be seen as a positive development for the company's lead candidate.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80